Botanical species · safety record

Cytisus scoparius

The EFSA Compendium of Botanicals holds 6 constituent measurements for Cytisus scoparius. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cytisus scoparius (L.) Link

6Constituent measurements

0Safety records

3Cited sources

10Licensed products (Canada)

Also recorded as

Sarothamnus scoparius (L.) W.D.J.Koch

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 10 licensed products naming Cytisus scoparius as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Aerial parts
Freshly stripped flowers plus leaves and young tips of shoots accumulated during harvesting
Herb
Young flowering twigs

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-sparteine	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
(-)-sparteine	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Lupanine	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
(-)-sparteine	Aerial part of plants	Solvent extraction	≤ 1.026 Percent	Unspecified	No resolvable identifier
(-)-sparteine	Aerial part of plants	Solvent extraction	≥ 0.863 Percent	Unspecified	No resolvable identifier
Quinolizidine alkaloids	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gresser, G., Witte, L., Dedkov, VP., Czygan, FC. A survey of quinolizidine alkaloids and phenylethylamine tyramine in Cytisus scoparius (Leguminosae) from different origins . Zeitschrift fur naturforschung c-a journal of biosciences, 1996, vol. 51, no. 11-12, p. 791-801.
Gilfillan, F. A., Logan, Felipe P. The alkaloidal content of Oregon-grown Cytisus scoparius (Scotch broom). Journal of the american pharmaceutical association (1912-1977), 1936, vol. 25, p. 505-6.
SAITO, K., SUZUKI, H., YAMASHITA, Y., MURAKOSHI, I. ISOLATION AND ENZYMATIC-SYNTHESIS OF AN ESTER ALKALOID, (-)-3-BETA-HYDROXY-13-ALPHA-TIGLOYLOXYLUPANINE, FROM CYTISUS-SCOPARIUS . Phytochemistry, 1994, vol. 36, no. 2, p. 309-311. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature